Simavita Limited announced the appointment of Mr. Warren Bingham as a Director of the company. Mr. Bingham's appointment is subject to TSX-V approval as well as shareholder approval which will be sought at a Special Meeting that the company anticipates will be held in late April /early May 2015. Over more than 20 years, Mr. Bingham has worked extensively in the field of medical devices and technologies, with expertise in domestic and international markets, health economics, regulatory and clinical affairs and business development.

Mr. Bingham currently provides consulting and advisory services to the life science, medtech and biotech sectors.